Overview Dispersin B is a glycoside hydrolase enzyme used in research for studying PNAG-dependent biofilm disruption. This guide provides practical protocols for researchers working with Dispersin B in laboratory settings.
> Research Use Only: Dispersin B is sold exclusively for laboratory research. It is not intended for human or animal therapeutic use.
Enzyme Handling & Storage - Storage temperature: -20°C (lyophilized) or -80°C (solution form) for long-term storage - Working aliquots: Store at 4°C for up to 2 weeks; avoid repeated freeze-thaw cycles - Buffer compatibility: Active in PBS, sodium acetate buffer (pH 5.5–6.0), and HEPES buffer - Optimal pH: 5.5–6.0 for maximum enzymatic activity - Temperature: 37°C for in vitro biofilm assays
Standard Biofilm Disruption Assay Protocol
### Materials
- 96-well polystyrene microtiter plates
- Bacterial culture (PNAG-producing organism, e.g., S. epidermidis RP62A)
- Dispersin B (research grade, ≥95% purity)
- Crystal violet staining solution (0.1% in water)
- Acetic acid (33%) for crystal violet solubilization
- Biofilm formation: Inoculate wells with bacterial suspension (OD600 = 0.05) in tryptic soy broth + 0.5% glucose; incubate 24h at 37°C static
- Washing: Remove planktonic cells by washing 3× with PBS; blot dry
- Dispersin B treatment: Add Dispersin B (25–100 μg/mL in PBS) to biofilm-coated wells; incubate 1h at 37°C
- Washing: Remove dispersed cells and enzyme by washing 3× with PBS
- Crystal violet staining: Add 0.1% crystal violet; incubate 15 min at RT; wash 3× with water; dry
- Quantification: Solubilize with 33% acetic acid; read absorbance at 595 nm
### Expected Results
- 25 μg/mL Dispersin B: 40–60% biofilm reduction (strain-dependent)
- 100 μg/mL Dispersin B: 70–90% biofilm reduction in PNAG-positive strains
- No significant activity against PNAG-negative strains (negative control validation)
Combination Antimicrobial Protocol
- Form biofilm as above (24h)
- Treat with Dispersin B (50–100 μg/mL) for 1h
- Without washing, add antibiotic at 1×, 4×, and 16× MIC concentrations
- Incubate additional 24h
- Assess viability by CFU counting or resazurin assay
Positive Control Organisms - Staphylococcus epidermidis RP62A (ATCC 35984) — high PNAG producer, standard reference strain - Staphylococcus aureus MN8 — PNAG-positive clinical isolate
Negative Control Organisms - Pseudomonas aeruginosa PAO1 — alginate-based biofilm, Dispersin B-insensitive
---
This guide is for scientific reference only. All compounds are for research use only and not for human or animal consumption.
See Also: Dispersin B Research Overview · Biofilm Research Methods Overview · Antibiofilm Peptide Strategies in Research